Comprehensive Report on Isonics Corporation Available from Crystal Research Associates.Business Editors GOLDEN, Colo.--(BUSINESS WIRE)--May 20, 2004 Executive Informational Overview Provides Detailed Information to Assist Investors Isonics Corporation (Nasdaq:ISON), a leader in the development of isotopically engineered semiconductor materials Semiconductor materials are insulators at absolute zero temperature that conduct electricity in a limited way at room temperature (see also Semiconductor). The defining property of a semiconductor material is that it can be doped with impurities that alter its electronic properties utilizing advances in nanotechnology, and a supplier of silicon-on-insulator (SOI (Silicon On Insulator) A chip architecture that increases transistor switching speed by reducing capacitance (build-up of electrical charges in the transistor's elements), and thus reducing the discharge time. The power requirement is also reduced in some designs. ) wafers to the semiconductor industry and isotopes for life sciences and health care applications, announced today that a comprehensive report on the Company has been published by Crystal Research Associates and is available for viewing and/or download for all interested parties. The report provides extensive details about the Company, its strategy and its vision for the future. Interested parties can access the report at www.crystalra.com or www.isonics.com. James E. Alexander, Isonics' President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , remarked: "As part of our strategy to maximize investor communications and awareness of Isonics, we are pleased to have this report, paid for the company, readily available for all our current and potential investors. With all the scrutiny that equity research has come under in recent years, we like the fact that Crystal has provided a no-frills, factual report on the Company." Crystal Research Associates, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , an independent research firm based in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , provides a new breed of independent stock research, presenting a company's Facts Without Fiction(TM). Its signature product, the Executive Informational Overview(TM) (EIO (Enhanced I/O) A hardware interface for HP printers that is used for adding an internal print server and network adapter, a hard disk and other plug-in functionality. EIO cards are smaller than previous MIO cards and more energy efficient. They use the PCI bus. See MIO. (TM)), in which it profiled Isonics, fully details a company's story in an honest, straight-forward, and purely factual manner. As such, Crystal Research affords the investment community an opportunity to learn about a company and industry without potential bias to forecasts and projected valuations. About Isonics Corporation Isonics Corporation has three business segments: (1) Isonics Semiconductor, (2) Isonics Life Sciences, and (3) Homeland Security Noun 1. Homeland Security - the federal department that administers all matters relating to homeland security Department of Homeland Security executive department - a federal department in the executive branch of the government of the United States . Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Through advances in nanotechnology, the Company is also focused on research and development opportunities for further, value-added product and application development. Isonics' Life Sciences division markets and sells stable isotopes stable isotope n. An isotope of an element that shows no tendency to undergo radioactive breakdown. for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and radioisotopes and stable isotopes, such as oxygen-18 for positron emission tomography positron emission tomography: see PET scan. positron emission tomography (PET) Imaging technique used in diagnosis and biomedical research. (PET) imaging. Stable isotopes can be thought of as ultra pure materials. This high degree of purification provides enhanced properties as compared to natural materials. Our efforts in the Homeland Security segment are nascent at the present time as we proceed to develop further our neutron-based detection technology. Additional information may be obtained at the Company's Web site at http://www.isonics.com. Cautionary Statement Except for historical information contained herein, this document contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2003, and its quarterly report on Form 10-QSB for the nine months ended January 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion